This is a serious infection where a type of fungus called Candida gets into your bloodstream. It's a form of invasive candidiasis, meaning the infection is spreading into your body's tissues. It can make you very sick and requires prompt medical treatment.
Every report comes from a Lived member, sent anonymously.
Have you tried Diflucan (Fluconazole) for Candida in the Blood?
Candidemia is an infection in which Candida, a type of yeast, is growing in the bloodstream. Candida normally lives on the skin and in the mouth and gut without causing harm, and it is familiar as the cause of thrush and vaginal yeast infections. Those are surface infections. Candidemia is different: once the yeast is in the blood, it can travel to the heart, eyes, bones and other organs, and the infection can be life-threatening. Candidemia is one form of invasive candidiasis, the term for Candida infections of the blood and deep tissues. It almost always develops in people who are already seriously ill, most often during a hospital stay. It has no distinctive symptoms of its own. It may show up as nothing more than a fever, or it may look exactly like sepsis caused by bacteria (a dangerous whole-body reaction to infection), with falling blood pressure and organs beginning to fail.
The immune system, an intact gut lining and healthy skin normally keep Candida in check. Candidemia happens when those defenses are weakened or bypassed. The yeast can cross from the gut into the blood after abdominal surgery, chemotherapy or other damage to the intestinal lining. It can also enter through medical devices, especially a central venous catheter (a long-term IV line that ends in a large vein near the heart). Candida can coat these devices with a sticky layer called a biofilm, where it is hard for medicine to reach. Some Candida can also spread in hospitals on hands, equipment or contaminated solutions. The main risk factors reflect serious illness and intensive medical care: a long hospital stay, especially in an intensive care unit; central lines; total parenteral nutrition (all nutrition given by vein); recent abdominal surgery; kidney failure or dialysis; broad-spectrum antibiotics, which clear away bacteria that normally compete with yeast; cancer and chemotherapy; and medicines that suppress the immune system. Very premature and low-birth-weight babies in neonatal intensive care are also at risk. These factors raise the odds of infection, but most people who have them never develop candidemia.
The diagnosis rests on blood cultures, in which samples of blood are placed in bottles and watched in the laboratory to see whether Candida grows. Cultures usually take two to three days to turn positive, and they miss many cases, detecting on average only about 40 percent. For that reason, doctors draw more than one set of cultures, and when a seriously ill person with risk factors gets worse, they may start antifungal treatment before results are back. Finding Candida in a urine or sputum sample is different: it often reflects yeast living on the surface rather than a bloodstream infection. Once Candida grows, the laboratory identifies the species and often tests which antifungal medicines work against it. This matters because some species, such as Candida glabrata and Candida auris, are more likely to resist common drugs. Some hospitals also use a blood test called beta-D-glucan, which detects a component of fungal cell walls. A negative result helps rule out infection, but a positive one does not prove that Candida is the cause. Because the yeast can settle in other organs, the care team also looks for spread. Repeat blood cultures show whether the infection has cleared. An eye examination can find infection at the back of the eye, which can threaten vision even when it causes few symptoms at first. An echocardiogram (an ultrasound of the heart) looks for infection of the heart valves in people at higher risk, such as those with an artificial valve, a new heart murmur or cultures that stay positive.
Candidemia is treated with antifungal medicine, started as early as possible, because delays are associated with higher death rates. In adults, the usual first choice is an echinocandin, a class of intravenous antifungals that includes micafungin, caspofungin and anidulafungin. Echinocandins work against most Candida species and have done better than fluconazole in critically ill people. Once a person is stable and the species is known to be susceptible, treatment is often switched to fluconazole (Diflucan), an antifungal that can be taken by mouth, usually after five to seven days. Switching to pills shortens the time on IV treatment. Amphotericin B, an older intravenous antifungal that can strain the kidneys, is used for some resistant infections and is often the first choice in newborns, for whom fluconazole or an echinocandin are alternatives. Because echinocandins reach the inside of the eye poorly, amphotericin B or fluconazole is preferred when the infection has reached the eye. Rezafungin (Rezzayo), a once-weekly echinocandin, is approved in the US for adults and children 12 and older who have limited or no other options. Removing the source of the infection matters as much as the medicine. A central line that may be infected is usually taken out within a day or two of diagnosis, because yeast growing on the catheter can keep reseeding the blood. An abscess or other collection of infection may need to be drained. When candidemia has not spread to other organs, treatment usually continues for 14 days after the first blood culture that shows no growth. Infection of the heart valves, eye or bone needs much longer treatment, from several weeks to months, and sometimes surgery. An infectious diseases specialist is often involved, which large studies associate with better survival.
Candidemia is a serious infection. In one large study of adults, about 4 in 10 people with Candida in the blood had died within 90 days, compared with fewer than 2 in 10 similar hospital patients without it. Much of that risk reflects how ill people already were, and outcomes tend to be better when antifungal treatment starts early, infected lines come out promptly and the infection has not spread. For most people, care takes place in the hospital alongside treatment of the illness that made them vulnerable. Repeat blood cultures, a new IV line, an eye examination and sometimes a heart ultrasound are common in the first week of treatment. Recovery often depends as much on that underlying illness as on the infection itself. When the infection has reached the eye, heart or bone, treatment and follow-up stretch over weeks or months and may include surgery or eye procedures. In very premature babies, invasive Candida infection is linked with later problems in development, vision and hearing, which is worth discussing with the baby's care team.
Candidemia is usually found and treated in the hospital, so questions about it mostly arise during treatment and after discharge. During or after treatment, contact the care team promptly about fever or chills that return, or about new vision problems such as blurring or spots, which can mean the infection has persisted or reached the eye. If someone who has or recently had candidemia becomes confused, breathes very fast, or has a racing heart with clammy skin, seek emergency care, because these can be signs of sepsis.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Candida in the Blood is like, what's helped you, or ask the community a question.